46,000ft² Radioligand Therapy Manufacturing Facility
Sector: Manufacturing (Industrial) • Location: Denton, Texas, United States
Source: Gene Online
Novartis initiated construction of a new 46,000ft² radioligand therapy manufacturing facility in Denton, Texas. This facility represents an expansion of the company’s manufacturing and research presence in the United States and will focus on the production of radioligand therapies, a type of targeted cancer treatment.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | under construction |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Novartis initiated construction of a new 46,000ft² radioligand therapy manufacturing facility in Denton, Texas. This facility represents an expansion of the company’s manufacturing and research presence in the United States and will focus on the production of radioligand therapies, a type of targeted cancer treatment. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |